𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A Phase I report of paclitaxel dose escalation combined with a fixed dose of carboplatin in the treatment of head and neck carcinoma

✍ Scribed by Frank R. Dunphy; James H. Boyd; Han J. Kim; Cherie H. Dunphy; Bruce R. Harrison; Teresa L. Dunleavy; Jack J. Rodriguez; Erin M. McDonough; Jeffrey R. Minster; Jack G. Hilton


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
151 KB
Volume
79
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


Thirty-six patients with untreated Stage III/IV head and neck carcinoma were treated and were evaluable for toxicity. All patients had lesions that were


πŸ“œ SIMILAR VOLUMES


A Phase I dose escalation trial of conti
✍ Todd M. Zimmerman; David L. Grinblatt; Rebecca Malloy; Stephanie F. Williams πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 73 KB πŸ‘ 2 views

## BACKGROUND. Paclitaxel, an effective chemotherapeutic agent in the management of breast carcinoma, may have activity in women whose disease has recurred after high dose chemotherapy. With this is mind the authors explored the addition of a 120-hour continuous infusion of paclitaxel to a previou

A Phase I–II trial of escalating doses o
✍ Charles A. Koller; Hagop M. Kantarjian; Eric J. Feldman; Susan O'Brien; Mary Bet πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 71 KB πŸ‘ 2 views

## BACKGROUND. Cytarabine is an essential drug for inducing remission of acute myelogenous leukemia, and it is also one the most effective drugs used as salvage therapy for patients with all types of relapsed acute leukemia. Nevertheless, there is considerable room for improvement in the treatment